Time
|
Duration
|
Type
|
Presenting person
|
Title
|
Date Unspecified |
|
|
|
Invited oral |
Maciej Wieczorek |
RNAi - breakthrough technology gives hope for breakthrough therapeutics |
May 10th, Monday |
|
| 09:15 |
00:30:00 |
Invited oral |
Jacek Kuźnicki |
High throughput calcium screens for identification of drug targets and drug discovery in neurodegenerative diseases |
| 09:45 |
00:30:00 |
Invited oral |
Karol L. Grela |
Olefin metathesis as an emerging tool in the synthesis of natural and bioactive compounds |
| 10:15 |
00:20:00 |
Oral |
Zdzisław Chilmonczyk |
Alkyl-nitroquipazine derivatives as serotonin transporter and 5-HT1A receptor ligands |
| 10:35 |
00:20:00 |
Oral |
Michał Fedoryński |
An efficient preparation of 3,5-bis(2-cyanoisopropyl) toluene-key intermediate in Anastrozole synthesis |
| 11:30 |
00:30:00 |
Invited oral |
Andrzej Kutner |
Synthetic Technologies of Pharmaceutical Substances |
| 12:00 |
00:20:00 |
Oral |
Katarzyna Kulig |
Design and synthesis of hybrid structures of pyrrolidin-2-one and arylalkylpiperazine as compounds with potential cardiovascular activity* |
| 12:20 |
00:20:00 |
Oral |
Beata Kolesińska |
Traceless chiral coupling reagent. A new concept for synthesis of optically active products from racemic carboxylic acids. |
| 12:40 |
00:20:00 |
Oral |
Krzysztof Jóźwiak |
An old drug with new perspectives: How stereochemistry of fenoterol and fenoterol derivatives influences the β-adrenergic binding and the G-protein coupling selectivity. |
| 13:00 |
00:20:00 |
Oral |
Sławomir Milewski |
N-alkyl derivatives of nystatin with improved selective toxicity |
| 15:20 |
00:30:00 |
Invited oral |
Tomasz Ciach |
Particles for controlled drug delivery |
| 15:50 |
00:20:00 |
Oral |
Bartłomiej Furman |
Cyclic Enaminones as Building Blocks in the Synthesis of Piperidine-Containing Natural Products and Biolo- gically Active Compounds |
| 16:10 |
00:20:00 |
Oral |
Zbigniew J. Kamiński |
An Approach for Application of Synthetic Peptides as Markers of Atherosclerotic Diseases |
| 16:30 |
00:20:00 |
Oral |
Barbara Malawska |
Multi-target-directed ligands in design and discovery of potential drugs for Alzheimer’s disease |
May 11th, Tuesday |
|
| 09:00 |
00:30:00 |
Invited oral |
Bogusław A. Buszewski |
New solutions and challenges in chromatography and related techniques. Quo vadis separation sciences? |
| 09:30 |
00:30:00 |
Invited oral |
Jozef Dulak |
New anti-angiogenic drugs |
| 10:00 |
00:20:00 |
Oral |
Katarzyna A. Koziak |
Endothelial P2Y receptors as novel targets for a pharmacological intervention |
| 10:20 |
00:20:00 |
Oral |
Kamil K. Kamiński |
Cationic chitosan derivative for heparin reversal - in vitro and in vivo studies in rats |
| 11:10 |
00:30:00 |
Invited oral |
Grzegorz Węgrzyn |
The use of genistein in treatment of genetic diseases |
| 11:40 |
00:20:00 |
Oral |
Jan Mazerski |
Microcalorimetric measurements in design of anti-tumor drugs |
| 12:00 |
00:20:00 |
Oral |
Zofia Lipkowska |
Design of novel peptide dendrimers: antimicrobial and anticancer activity |
| 12:20 |
00:20:00 |
Oral |
Mateusz Nowak |
Selvita: Life science solutions |
| 12:40 |
00:20:00 |
Oral |
Artur Panczakiewicz |
A Local SCF approach to all-atom semiempirical quantum-mechanical protein modeling and ligand docking |
| 15:00 |
00:30:00 |
Invited oral |
Aleksander P. Mazurek |
Molecular properties of active ingredients
Impact on bioavailability
The biopharmaceutics classification system |
| 15:30 |
00:20:00 |
Oral |
Ryszard Ostaszewski |
Chemoenzymatic approach to the synthesis of bioactive tripeptide mimetics for treatment of cancer |
| 15:50 |
00:20:00 |
Oral |
Mariusz Sacharczuk |
Comparable antinociceptive effect of biphalin in mice selected for high and low swim stress-induced analgesia after blood-brain barrier disruption caused by hyperosmolar mannitol administration |
| 16:10 |
00:20:00 |
Oral |
Małgorzata Milczarek |
Confocal microscopy - a novel tool in drug analysis |
May 12th, Wednesday |
|
| 09:00 |
00:30:00 |
Invited oral |
Waldemar Priebe |
Exploration of sugar-based inhibitors of glycolysis to target brain tumors |
| 09:30 |
00:30:00 |
Invited oral |
Marcin Nowotny |
Protein crystallography as a tool in drug discovery |
| 10:00 |
00:20:00 |
Oral |
Monika Lamparska-Przybysz |
Novel small molecule STAT3 inhibitors in cancer therapy. |
| 10:20 |
00:20:00 |
Oral |
Teresa M. Brodniewicz |
Preclinical evaluation of new chemical entity. |
| 11:10 |
00:30:00 |
Invited oral |
Tomasz G. Wasiela |
Good Laboratory Practice as the quality system ensuring mutual acceptance of test results in the registration of pharmaceutical products. |
| 11:40 |
00:20:00 |
Oral |
Kurt Kristiansen |
Homology modeling of G-protein coupled receptors |
| 12:00 |
00:20:00 |
Oral |
Andrzej Sikorski |
Polymer chains as molecular dispensers. Monte Carlo simulations of simple models |
| 12:20 |
00:20:00 |
Oral |
Andrzej W. Lipkowski |
Keratin associated proteins (KAPs) as a new biomaterials for applications in medicine and cosmetology |
| 12:40 |
00:20:00 |
Oral |
Krzysztof Kurowski |
New phenylpropanoic acid derivative with antidiabetic potential acting as a partial PPAR gamma agonist – preclinical studies. |
| 15:00 |
00:30:00 |
Invited oral |
Marek Chmielewski |
From unsaturated sugar α,β-lactones to β-lactams. The synthesis.
Od α,β-nienasyconych laktonów cukrowych do syntezy β-laktamów. |
| 15:30 |
00:20:00 |
Oral |
Zbigniew Kałuża |
Stereoselective synthesis of isoquinoline alkaloids with a quaternary carbon seterocenter |
| 15:50 |
00:20:00 |
Oral |
Lech Kozerski |
Diffusion ordered NMR spectroscopy application to medicines control and research |
| 16:10 |
00:20:00 |
Oral |
Zofia Mazerska |
Polymorphism and the level of P450 gene expression in drug metabolism |
| 16:30 |
00:20:00 |
Oral |
Tomasz Kosmalski |
Enantioselective reduction of α-dialkylamino ketones |
